BetaGlue Technologies
Milano
About BetaGlue Technologies
Among the company's products is a beta-emitting adhesive that aids in the regulation of radioactive injection straight into tumors. It allows clinicians to help prevent problems after lung and liver biopsies and other localized treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $29.8M
- Last round: Series Unknown (Jun 2024)
- Website: betaglue.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Wellness
Social Profiles
Canonical: https://fsome.com/organization/betaglue-technologies-5619 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.